Somatic hypermutation in autoimmune thyroid disease

被引:0
|
作者
McIntosh, R
Watson, P
Weetman, A [1 ]
机构
[1] Univ Sheffield, No Gen Hosp, Ctr Clin Sci, Dept Med, Sheffield S5 7AU, S Yorkshire, England
[2] Queens Med Ctr, Dept Clin Lab Sci, Div Mol & Cellular Immunol, Nottingham NG7 2UH, England
基金
英国惠康基金;
关键词
D O I
暂无
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Autoimmune thyroid disease is one of the most common autoimmune diseases. There is typically patient antibody (Ab) reactivity to one or more of the antigens thyroglobulin (Tg), thyroid peroxidase (TPO) and the thyroid stimulating hormone receptor (TSHr). With the advent of combinatorial library technology, there has been an enormous increase in the number of sequences from Ab to Tg and TPO. The repertoire of both Tg and TPO Ab is restricted and indicates the importance of somatic hypermutation in the development of the high affinity Ab response. However, there are still too few sequences to determine patterns in which the mutation occurs, which residues are introduced during substitution and how individual substitutions affect the affinity of the Ab. Ab to the TSHr are of far greater pathological significance than those to Tg and TPO, but the current repertoire of Ab to the TSHr has yet to include the high affinity IgG Ab characteristic of patient serum Ab. instructive analysis of the role of somatic hypermutation in the development of TSHr Ab therefore still awaits the isolation of the pathologically active repertoire. Despite this, the Ab response in thyroid autoimmunity remains one of the best characterised of human autoimmune diseases.
引用
收藏
页码:219 / 231
页数:13
相关论文
共 50 条
  • [1] SOMATIC HYPERMUTATION
    NEUBERGER, MS
    MILSTEIN, C
    [J]. CURRENT OPINION IN IMMUNOLOGY, 1995, 7 (02) : 248 - 254
  • [2] Somatic hypermutation
    Weitzman J.B.
    [J]. Genome Biology, 3 (1):
  • [3] The insertion/deletion phenotype in somatic hypermutation and a new model for somatic hypermutation
    Wilson, PC
    Capra, JD
    [J]. IMMUNOLOGIST, 1998, 6 (02): : 48 - 53
  • [4] Analysis of VH gene rearrangement and somatic hypermutation in type 1 autoimmune pancreatitis
    Okumura, Fumihiro
    Sakuma, Hidenori
    Nakazawa, Takahiro
    Hayashi, Kazuki
    Naitoh, Itaru
    Miyabe, Katsuyuki
    Yoshida, Michihiro
    Yamashita, Hiroaki
    Ohara, Hirotaka
    Inagaki, Hiroshi
    Joh, Takashi
    [J]. PATHOLOGY INTERNATIONAL, 2012, 62 (05) : 318 - 323
  • [5] The regulation of somatic hypermutation
    Besmer, E
    Gourzi, P
    Papavasiliou, FN
    [J]. CURRENT OPINION IN IMMUNOLOGY, 2004, 16 (02) : 241 - 245
  • [6] Somatic hypermutation: Another piece in the hypermutation puzzle
    Winter, DB
    Gearhart, PJ
    [J]. CURRENT BIOLOGY, 1995, 5 (12) : 1345 - 1346
  • [7] Immunoglobulin somatic hypermutation
    Teng, Grace
    Papavasiliou, E. Nina
    [J]. ANNUAL REVIEW OF GENETICS, 2007, 41 : 107 - 120
  • [8] The biochemistry of somatic hypermutation
    Peled, Jonathan U.
    Kuang, Fei Li
    Iglesias-Ussel, Maria D.
    Roa, Sergio
    Kalis, Susan L.
    Goodman, Myron E.
    Scharff, Matthew D.
    [J]. ANNUAL REVIEW OF IMMUNOLOGY, 2008, 26 : 481 - 511
  • [9] Targeting of somatic hypermutation
    Valerie H. Odegard
    David G. Schatz
    [J]. Nature Reviews Immunology, 2006, 6 : 573 - 583
  • [10] Somatic immunoglobulin hypermutation
    Diaz, M
    Casali, P
    [J]. CURRENT OPINION IN IMMUNOLOGY, 2002, 14 (02) : 235 - 240